| |
|
| |
| DETAILS |
|
Enterprise healthcare customers are demanding that vendors & service organizations come with data - proving that their solutions actually drive clinical & operational outcomes.
What preseed & seed teams get wrong about early pilots & validation studies is that they rarely solve for endpoints that actually prove clinical or operational impact or have any sway with potential enterprise healthcare buyers.
Join MarkOne Health for a panel including enterprise buyers & founders on what to test, how to test, & how to use those outcomes to get traction for your healthcare solutions.
Evan Huang is CTO of Lightbeam Health. He was previously the cofounder of Caresignal, a national-scale RPM platform which exited to Lightbeam in 2021. At Caresignal, Evan established a 5k patient umbrella IRB under which they ran clinical studies on all of their programs & published many towards establishing both ROI & clinical efficacy for new payer customers.
David Berger MD MHCM is a digital health entrepreneur & advisor Dr. Berger is formerly a surgical oncologist & physician executive. He has been CEO of University Hospital at Downstate & COO of Baylor St. Luke's Medical Center. He brings a wealth of customer perspective both evaluating & implementing digital health solutions at health system scale.
Ed Jiang is an experienced actuary & currently VP of Medical Economics at CareAbout, a 6k+ provider primary care ACO. He has extensive experience on both the payer & provider side of healthcare economics & leverages that in his advisory & consulting practice, Dr. ROI.
By signing up for this event, you're consenting to event photography & will be added to our monthly mailer of MarkOne & other NYC Healthtech events.
|
|
|
|
|
|
|
|
